The compound heterozygous mutations encoded in the ERS domain of EPRS identified in two patients with diabetes and bone disease, P14R and E205G, were not previously associated with human disease, and the consequences of these mutations on ERS catalytic function in vitro or on protein synthesis and homeostasis in vivo were unknown. Here, EPRS1 is linked to diabetes mellitus.